Growth Metrics

RemSleep Holdings (RMSL) Free Cash Flow (QoQ) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 RemSleep Holdings - - -7,636.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -6.07%
Sep 30, 2025 13.62%
Jun 30, 2025 -28.32%
Mar 31, 2025 43.93%
Dec 31, 2024 27.89%
Sep 30, 2024 -79.27%
Jun 30, 2024 -33.86%
Mar 31, 2024 38.75%
Dec 31, 2023 -4.14%
Sep 30, 2023 41.35%
Jun 30, 2023 -11.32%
Mar 31, 2023 15.43%
Dec 31, 2022 -44.55%
Sep 30, 2022 85.96%
Jun 30, 2022 -608.64%
Mar 31, 2022 -104.68%
Dec 31, 2021 -29.03%
Sep 30, 2021 40.32%
Jun 30, 2021 -75.69%
Mar 31, 2021 -30.98%
Dec 31, 2020 -23.37%
Sep 30, 2020 71.41%
Jun 30, 2020 -105.78%
Mar 31, 2020 33.68%
Dec 31, 2019 -85.20%
Sep 30, 2019 -17.81%
Jun 30, 2019 11.59%
Mar 31, 2019 -70.43%
Dec 31, 2018 11.50%
Sep 30, 2018 -18.99%
Jun 30, 2018 -35.99%
Mar 31, 2018 -19.37%
Dec 31, 2017 -3.31%
Sep 30, 2017 27.61%
Jun 30, 2017 -57.08%
Mar 31, 2017 81.85%
Dec 31, 2016 -3,683.53%
Sep 30, 2016 197.74%
Jun 30, 2016 88.26%
Mar 31, 2016 -98.11%
Jun 30, 2015 -62.62%
Mar 31, 2015 71.57%
Dec 31, 2013 37.43%
Sep 30, 2013 99.54%
Jun 30, 2013 -393,564.41%
Mar 31, 2013 100.35%
Dec 31, 2012 -100.39%
Sep 30, 2012 200.18%
Jun 30, 2012 -93,126.38%
Mar 31, 2012 72.97%
Dec 31, 2011 -338.04%
Sep 30, 2011 153.31%
Jun 30, 2011 -165.46%
Mar 31, 2011 89.90%
Dec 31, 2010 43.43%